AVEO Pharmaceuticals
$0.6399876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.639
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0126 (-1.96%) Today
+$0.0076 (+1.20%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell AVEO and other stocks, options, ETFs, and crypto commission-free!
About AVEO
AVEO Pharmaceuticals, Inc. Common Stock, also called AVEO Pharmaceuticals, is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Read More Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
Employees
17
Headquarters
Cambridge, Massachusetts
Founded
2001
Market Cap
101.49M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
5.37M
High Today
$0.6599
Low Today
$0.6312
Open Price
$0.65
Volume
1.24M
52 Week High
$2.25
52 Week Low
$0.4692
Collections
AVEO Earnings
-$0.18
-$0.09
$0.01
$0.10
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
$0.10 per share